SLC2A1 and colorectal carcinoma: LncRNA SNHG15 knockdown inhibited CRC proliferation, resistance to 5‐FU chemotherapy and glycolysis, potentially through the regulation of TYMS, BCL2, GLUT1 and PKM2 expression [93].